South Korea Oncology Drugs Market Size & Outlook, 2026-2033
The oncology drugs market in South Korea is expected to reach a projected revenue of US$ 13,342.7 million by 2033. A compound annual growth rate of 14.36% is expected of South Korea oncology drugs market from 2026 to 2033.
- Pharmaceuticals
- Oncology Drugs
- Oncology Drugs Market Outlook
- Oncology Drugs
Revenue, 2025 (US$M)
$4,591.3
Estimate, 2026 (US$M)
$5,215.9
Forecast, 2033 (US$M)
$13,342.7
CAGR, 2026 - 2033
14.4%
Global Market
Related Markets
Prism AI by Grand View ResearchFree to try
Ask a question about the oncology drugs market
Every figure cited from GVR research
South Korea oncology drugs market highlights
- The South Korea oncology drugs market generated a revenue of USD 4,591.3 million in 2025 and is expected to reach USD 13,342.7 million by 2033.
- The South Korea market is expected to grow at a CAGR of 14.36% from 2026 to 2033.
- In terms of segment, chemotherapy was the largest revenue generating drug class in 2025.
- Cell & Gene Therapy is the most lucrative drug class segment registering the fastest growth during the forecast period.
Oncology drugs market data book summary
| Market revenue in 2025 | USD 4,591.3 million |
| Market revenue in 2033 | USD 13,342.7 million |
| Growth rate | 14.36% (CAGR from 2026 to 2033) |
| Largest segment | Chemotherapy |
| Fastest growing segment | Cell & Gene Therapy |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Radiopharmaceuticals, Cell & Gene Therapy |
| Key market players worldwide | Roche Holding AG, Merck & Co. Inc., AstraZeneca, Bristol Myers Squibb, Pfizer, Inc., Novartis AG, Johnson & Johnson, Eli Lilly and Company, GSK PLC, Amgen |
Other key industry trends
- In terms of revenue, South Korea accounted for 1.8% of the global oncology drugs market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China oncology drugs market is projected to lead the regional market in terms of revenue in 2033.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 9,683.2 million by 2033.
No credit card required*
Publish Date: Aug 19, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Oncology Drugs Market Scope
Oncology Drugs Market segmentation & scope
Others
Oncology Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Roche Holding AG | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| GSK PLC | View profile | 70,200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | www.gsk.com |
| Johnson & Johnson | View profile | - | - | - |
| Bristol Myers Squibb | View profile | - | - | - |
| Novartis AG | View profile | - | - | - |
| AstraZeneca | View profile | - | - | - |
| Amgen | View profile | - | - | - |
| Merck & Co. Inc. | View profile | - | - | - |
| Eli Lilly and Company | View profile | - | - | - |
| Pfizer, Inc. | View profile | - | - | - |
South Korea Oncology Drugs Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Oncology Drugs Market Outlook will help companies and investors design strategic landscapes.
Chemotherapy was the largest segment with a revenue share of 35.53% in 2025.
Horizon Databook has segmented the South Korea oncology drugs market based on chemotherapy, targeted therapy, immunotherapy, hormonal therapy, radiopharmaceuticals, cell & gene therapy covering the revenue growth of each sub-segment from 2021 to 2033.
- South Korea Oncology Drugs Market Drug Class Outlook (Revenue, USD Million , 2021-2033)
- Chemotherapy
- Targeted Therapy
- Immunotherapy
- Hormonal Therapy
- Radiopharmaceuticals
- Cell & Gene Therapy
- Others
- South Korea Oncology Drugs Market Cancer Outlook (Revenue, USD Million , 2021-2033)
- Solid Tumors
- Hematologic Malignancies
- South Korea Oncology Drugs Market Route of Administration Outlook (Revenue, USD Million , 2021-2033)
- Oral
- Injectable
- Others
- South Korea Oncology Drugs Market Drug Outlook (Revenue, USD Million , 2021-2033)
- Branded
- Generic & Biosimilar
- South Korea Oncology Drugs Market Distribution Channel Outlook (Revenue, USD Million , 2021-2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Reasons to subscribe to Oncology Drugs Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Oncology Drugs Market Outlook databook
- Our clientele includes a mix of Oncology Drugs Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea Oncology Drugs Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into South Korea Oncology Drugs Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
South Korea Oncology Drugs Market, 2021-2033 (US$M)
South Korea Drug Class - Oncology Drugs Market Statistics, 2025 - 2033 (US$M)
